the Biotechnology Organization represents over 1,000 biotechnology companies and their members all over the country and in every State. California, Massachusetts, and Maryland have the highest concentration of biocompanies in the United States. I think what people understand and what my colleagues understand is that the biofield is a fairly new field. When I was in medical school, these biotech companies were not out there. The drugs they are looking at today were nonexistent. For the most part, they are in their infancy today. Fifty years from now and looking back, we will see on the curve an increase that right now we are at the beginning of. Of the 130 biotech drugs approved by the FDA, all were produced by fewer than 100 companies. As I just said, there are over 1,000 biotechnology companies that exist today. What that means is, if you have ten companies working at the early research stage to figure out what drug is going to cure HIV/AIDS, or reverse a certain case of emphysema or reverse that blood clot just about ready to cause a stroke in your brain, one company will ultimately produce an effective product. Many of these companies are small, emerging companies.
Editor's note · Context
Discussing the growth and importance of the biotechnology industry in the U.S.
Share
More from William H. Frist
After 33 years of service to the U.S. Senate, Linda Sebold has decided to retire. Linda began her Senate career with the Office of the Secretary of the Senate back in August of 1973, and until this day Linda remains totally dedicated to…
for more than 50 years, the North Atlantic Treaty Organization has served as a force for stability, security, and peace in Europe. It remains the foundation of security on the Continent and the cornerstone of U.S. engagement in Europe…
I rise to pay tribute to one who is known as Mr. Budget of the Senate. When I stepped up to the position of majority leader 4 years ago, my first priority was to hire a staff of capable advisers. When I stepped up, it happened very…
the legislation that leaves this Senate floor absolutely must achieve two goals: first, preserve the intelligence programs that we know have saved American lives; second, protect classified information from terrorists who could exploit it…





